Gilead Expecting A Quick Close With CymaBay Therapeutics – Merger Arbitrage Mondays

  • February 19, 2024

CymaBay Therapeutics: $31.17

Market Cap: $3.69 billion

When Gilead Sciences (GILD) announced its all cash acquisition of CymaBay (CBAY) last week for $32.50 per share in cash, it wasn’t as much the $3.26 billion price tag or the 36% premium it paid for the company that stood out. It was the expected closing indicated, which according to the press release was “the first quarter of 2024, subject to regulatory approvals and other customary closing conditions.”

This 49 day or earlier expected close is less than half the time it takes for most deals to close. It is so short, that I doubled checked to make sure that Gilead or CymaBay were not indicating a fiscal quarter that was different from the calendar quarter. Looking at the financial statements for both companies that was not the case.

CymaBay Therapeutics is a clinical-stage biopharmaceutical company headquartered in Newark, California. The company primarily focuses on innovative therapies for treating patients with liver and other chronic diseases. On February 12, 2024, CymaBay announced that the U.S. FDA has agreed to review its New Drug Application (NDA) for seladelpar. This is a treatment for managing primary biliary cholangitis (PBC), a chronic liver disease characterized by the progressive destruction of the bile ducts within the liver.

PBC disease

The deal comes as Gilead faces consecutive setbacks in its clinical trials. CymaBay’s investigational lead product candidate, seladelpar fits well with Gilead’s current liver treatment lineup.

CBAY Clinical Trials

The last time I looked at the time it takes deals to close was when I was writing my first book The Event-Driven Edge in Investing and mentioned the following in the merger arbitrage chapter of the book:

“Analyzing a list of 2,320 completed deals between 2010 and 2022, I noticed that on average deals took 131 days to close. The median time to completion was just 107 days, implying that some outlier deals like the acquisition of Change Healthcare by UnitedHealth Group (UNH) that took 635 days to complete or the acquisition of Xilinx by AMD that took 475 days to complete, skew the average.”

I am sure that the time it takes deals to close on average has increased since I did my analysis but biotech deals with the exception of Horizon Therapeutics and Seagen have continued to close within short periods of time. Recent examples include the acquisition of ImmunoGen by AbbVie, which was completed in 74 days. and the acquisition of Theseus Pharmaceuticals by Concentra Biosciences, which took even less time at 54 days.

The CymaBay deal trades at a spread of just 1.04% but because of the short closing timeline indicated, it works out to an annualized return of about  8.84%. You can find all the details of this deal here. Given the narrow spread, unless there is some expectation of a competing offer, the juice is not worth the squeeze with this one.


M&A activity declined last week with four new deals announced and three deals completed.

You can find all the active deals listed below in our Merger Arbitrage Tool (MAT) which automatically updates itself during market hours.

Merger Arbitrage

Deal Statistics:

Total Number of Deals Closed in 202413
Total Number of Deals Not Completed in 20243
Total Number of Pending Deals
Cash Deals49
Stock Deals22
Stock & Cash Deals3
Special Conditions8
Total Number of Pending Deals82
New Deals Announced in 2024$111.83 billion

New Deals:

  1. CBAY: The acquisition of CymaBay Therapeutics, Inc. (CBAY) by Gilead Sciences, Inc. (GILD) for $3.26 billion or $32.50 per share in cash.
  2. FREE: The acquisition of Whole Earth Brands (FREE) by Sababa Holdings for $593.91 million or $4.875 per share in cash. We added FREE as a potential deal to the Deals in the Works section on June 25, 2023, and the price after the news of the potential deal came out was $3.90.
  3. KNTE: The acquisition of Kinnate Biopharma Inc. (KNTE) by XOMA Corporation (XOMA) for -$71.33 million. Under the terms of the agreement, XOMA Corporation will acquire Kinnate for a price per share of Kinnate common stock of between $2.3352 and $2.5879 in cash, consisting of (i) a base cash price of $2.3352 per share and (ii) an additional cash amount of up to $0.2527 per share, plus one non-transferable contingent value right per share.
  4. HRT: The acquisition of HireRight Holdings Corporation (HRT) by investment funds affiliated with General Atlantic and Stone Point Capital for $1.65 billion or $14.35 per share in cash. We added HRT as a potential deal to the Deals in the Works section on December 11, 2023, and the price after the news of the potential deal came out was $13.02.

Approvals:

  1. SQNS: On February 12, 2024, shareholders of Sequans Communications (SQNSapproved the company’s merger with Renesas Electronics Corporation at a special meeting of shareholders.
  2. RYZB: On February 12, 2024, Bristol Myers Squibb (BMY) and RayzeBio (RYZB) announced that the waiting period under the HSR Act expired on February 9, 2024. Unless the tender offer is extended, the offer will expire on February 22, 2024.
  3. SP: On February 12, 2024, Shareholders of SP Plus (SPapproved the company’s merger with Metropolis Technologies at a special meeting of shareholders.
  4. FRLN: On February 12, 2024, shareholders of Freeline Therapeutics Holdings (FRLNapproved the company’s merger with Syncona at a special meeting of shareholders. The deal is expected to be completed on February 20, 2024.
  5. GAN: On February 13, 2024, shareholders of GAN Limited (GANapproved the company’s merger with Sega Sammy Creation at a special meeting of shareholders. The closing of the merger is expected to occur in late 2024 or early 2025.
  6. EAR: On February 13, 2024, shareholders of Eargo, Inc. (EARapproved the company’s merger with Patient Square Capital at a special meeting of shareholders.
  7. DSKE: On February 15, 2024, Daseke (DSKE) announced that the waiting period under the HSR Act expired on February 8, 2024. The company also received approval from the Commissioner of the Competition Act (Canada).
  8. CERE: On February 16, 2024, Shareholders of Cerevel Therapeutics Holdings (CEREapproved the company’s merger with AbbVie (ABBV) at a special meeting of shareholders.

Hurdles:

  1. ACI: Colorado Attorney General Phi Weiser  filed a lawsuit to block Albertsons (ACI) $25 billion sale to Kroger (KR) deal. He said that the supermarket chains’ proposal to divest 400 stores to C&S Wholesalers is “unpersuasive.” Colorado is seeking a preliminary injunction to stop the planned deal.
  2. CERE: On February 16, 2024, Cerevel Therapeutics Holdings (CERE) and AbbVie (ABBV) each received a request for additional information and documentary materials from the FTC in connection with the FTC’s review of the merger.

Updates:

  1. SNCE: On February 12, 2024, eMed commenced a cash tender offer to purchase all the outstanding shares of common stock of Science 37 Holdings (SNCE). The offer will expire on March 11, 2024.
  2. VIA: In its Preliminary proxy statement filed on February 12, 2024, Via Renewables (VIA) reported that it is preparing to file its application for approval with the Federal Energy Regulatory Commission (“FERC”), and anticipates obtaining approval before the date of the Special Meeting.
  3. SOVO: Campbell Soup Company (CPB) and Sovos Brands (SOVOcertified substantial compliance with the request for additional information and documentary materials issued by the FTC regarding Campbell’s proposed acquisition of Sovos Brands. The certification of substantial compliance triggers the start of a 30-day waiting period which is expected to expire on March 11, 2024, after which the sale can be finalized.

Shareholders Meeting Schedule:

  1. AYX: On February 12, 2024, Alteryx (AYX) announced that the special meeting of shareholders will be held on March 13, 2024.
  2. BATL: On February 12, 2024, Battalion Oil (BATL) announced that the special meeting of shareholders will be held on March 18, 2024.
  3. PGTI: On February 14, 2024, PGT Innovations (PGTI) announced that the special meeting of shareholders will be held on March 18, 2024.
  4. DSKE: On February 15, 2024, Daseke (DSKE) announced that the special meeting of shareholders will be held on March 26, 2024.
  5. CPE: On February 16, 2024, Callon Petroleum Company (CPE) announced that the special meeting of shareholders will be held on March 27, 2024.

Closed Deals:

  1. IMGN: The acquisition of ImmunoGen (IMGN) by AbbVie (ABBV) was completed on February 12, 2024. It took 74 days for this deal to be completed.
  2. THRX: The acquisition of Theseus Pharmaceuticals (THRX) by Concentra Biosciences was completed on February 14, 2024. It took 54 days for this deal to be completed.
  3. EAR: The acquisition of Eargo (EAR) by an affiliate of Patient Square Capital was completed on February 16, 2024. It took 54 days for this deal to be completed.

Weekly Spread Changes:

The table below shows weekly spread changes between February 9, 2024, and February 16, 2024.

SymbolQuoteAcquiring
Company
Acquiring
Company Quote
Current
Spread
Last Week
Spread
Spread Change
Weekly
Deal
Type
BATL6.01Fury Resources, Inc. (N/A)63.06%50.08%12.98%All Cash
WRK43.71Smurfit Kappa (SMFTF)41.556.50%-0.87%7.37%Cash Plus Stock
FGH1.3FG Financial Group, Inc. (FGF)1.332.31%-3.60%5.91%All Stock
GRCL10.135AstraZeneca (AZN)64.26-1.33%-3.75%2.42%Special Conditions
SAVE6.62JetBlue Airways Corporation (JBLU)6.95368.28%366.17%2.11%All Cash
VIA10.8Retailco, LLC (N/A)1.85%4.07%-2.22%All Cash
ACI21.58The Kroger Co. (KR)47.6426.27%28.54%-2.27%Special Conditions
CTLT58.14Novo Nordisk (NVO)124.019.22%11.97%-2.75%All Cash
GAN1.6Sega Sammy Creation Inc. (N/A)23.13%28.76%-5.63%All Cash
HMST13.6Firstsun Capital Bancorp. (FSUN)35.4513.26%20.02%-6.76%All Stock

Top 10 Merger Arbitrage Deals With The Largest Spreads:

Please do your own due diligence on deals with large spreads. Some of these large spreads might be related to regulatory issues or because of the way the deal is structured. We classify some of these deals as “special situation” deals in our merger arbitrage tool and provide additional details to help with the analysis. There may be unique situations related to special dividends, spinoffs, proration, etc. that need to be accounted for when looking at these spreads.

SymbolAnnounced
Date
Acquiring
Company
Closing
Price
Last
Price
Closing
Date
ProfitAnnualized
Profit
SAVE07/28/2022JetBlue Airways Corporation (JBLU)$31.00$6.6206/30/2024368.28%1010.69%
BATL12/15/2023Fury Resources, Inc. (N/A)$9.80$6.0103/31/202463.06%548.04%
MIXT10/10/2023PowerFleet, Inc. (PWFL)$13.39$9.1303/31/202446.61%405.04%
HA12/03/2023Alaska Air Group, Inc. (ALK)$18.00$14.0106/30/202528.48%20.87%
ACI10/14/2022The Kroger Co. (KR)$27.25$21.5803/31/202426.27%228.34%
GAN11/07/2023Sega Sammy Creation Inc. (N/A)$1.97$1.612/31/202423.13%26.63%
CPRI08/10/2023Tapestry, Inc. (TPR)$57.00$47.3206/30/202420.46%56.14%
X12/18/2023Nippon Steel (NISTF)$55.00$4609/30/202419.57%31.74%
ANSS01/16/2024Synopsys (SNPS)$387.82$329.88506/30/202517.56%12.87%
HMST01/16/2024Firstsun Capital Bancorp. (FSUN)$15.40$13.606/30/202413.26%36.38%

Deals In The Works

  1. CYTK: At the Oppenheimer conference, Cytokinetics (CYTK) CEO Robert Blum said the company is not conducting a sales process.
  2. VZIO: According to WSJ, Walmart (WMT) is in talks to buy smart television-manufacturer Vizio (VZIO) for more than $2 billion.

SPAC Arbitrage

Business Combination

  1. ARYD: On February 14, 2024, Adagio Medical, Inc. and ARYA Sciences Acquisition Corp IV (ARYDentered into a definitive agreement for a business combination.
  2. NNAG: On February 13, 2024, Nava Health MD, Inc. and 99 Acquisition Group Inc. (NNAGentered into a definitive merger agreement for a business combination.

Completed

  1. QFTA: On February 12, 2024, Quantum FinTech Acquisition Corporation (QFTA) and AtlasClear Holdings, Inc. (ATCHcompleted their business combination.
  2. LGST: On February 13, 2024, Semper Paratus Acquisition Corporation (LGST) and Tevogen Bio Inc. (TVGN) announced the completion of their business combination.
  3. PBAX: On February 14, 2024, Phoenix Biotech Acquisition Corp. (PBAX) and CERo Therapeutics, Inc. (CERO) announced the completion of their business combination.
  4. CHEA: On February 15, 2024, Chenghe Acquisition Co. (CHEA) and Semilux International Ltd. (SELXcompleted their business combination.

Terminated

  1. IVCP: On February 15, 2024, Swiftmerge Acquisition Corp. (IVCP) and HDL Therapeutics terminated their business combination.

List of all pending Merger Arbitrage deals:

TargetAnnounced
Date
AcquirerDeal
Type
Closing
Value
Deal
Price
Last
Price
Target VolumeEstimated
Closing Date
ReturnAnnualized
Return
+SAVE7/28/22JetBlue Airways Corporation (JBLU)All Cash$7.6 B$31.00$6.624,875,9906/30/24368.28%1018.34%
+BATL12/15/23Fury Resources, Inc. (N/A)All Cash$450 M$9.80$6.01103,5023/31/2463.06%561.40%
+MIXT10/10/23PowerFleet, Inc. (PWFL)All Stock$140 M$13.39$9.1372,5103/31/2446.61%414.91%
+HA12/03/23Alaska Air Group, Inc. (ALK)All Cash$1.19 B$18.00$14.01529,0366/30/2528.48%20.92%
+ACI10/14/22The Kroger Co. (KR)Special Conditions$24.6 B$27.25$21.586,107,9653/31/2426.27%233.91%
+GAN11/07/23Sega Sammy Creation Inc. (N/A)All Cash$85.73 M$1.97$1.6463,64712/31/2423.13%26.71%
+CPRI8/10/23Tapestry, Inc. (TPR)All Cash$8.5 B$57.00$47.32757,6986/30/2420.46%56.57%
+X12/18/23Nippon Steel (NISTF)All Cash$14.9 B$55.00$463,219,8449/30/2419.57%31.88%
+ANSS1/16/24Synopsys (SNPS)Cash Plus Stock$35 B$387.82$329.885444,2976/30/2517.56%12.90%
+HMST1/16/24Firstsun Capital Bancorp. (FSUN)All Stock$277.15 M$15.40$13.6218,2716/30/2413.26%36.66%
+FFNW1/11/24Global Federal Credit Union (N/A)Special Conditions$231.2 M$23.18$20.919,11012/31/2410.91%12.60%
+CTLT2/05/24Novo Nordisk (NVO)All Cash$16.5 B$63.50$58.143,071,24512/31/249.22%10.65%
+JNPR1/09/24Hewlett Packard Enterprise (HPE)All Cash$14.31 B$40.00$36.921,955,7693/31/258.34%7.50%
+CNSL10/16/23Searchlight Capital Partners and British Columbia Investment Management Corporation (N/A)All Cash$3.1 B$4.70$4.34613,9621/15/258.29%9.15%
+AMED6/26/23UnitedHealth Group Incorporated (UNH)All Cash$3.8 B$101.00$93.385321,9073/31/248.15%72.59%
+NS1/22/24Sunoco LP (SUN)All Stock$7.3 B$25.01$23.32815,4286/30/247.26%20.06%
+ICLK11/24/23TSH Investment Holding Limited (N/A)All Cash-$12.92 M$4.08$3.815,8313/31/247.09%63.09%
+AEL7/05/23Brookfield Reinsurance (BNRE) (BAM)Cash Plus Stock$4.3 B$59.15$55.25618,9966/30/247.05%19.50%
+HES10/23/23Chevron Corporation (CVX)All Stock$60 B$158.50$148.431,975,4416/30/246.78%18.75%
+WRK9/12/23Smurfit Kappa (SMFTF)Cash Plus Stock$23.24 B$46.55$43.711,652,1196/30/246.50%17.97%
+GTH10/11/23New Genetron Holding Limited and Genetron New Co Limited (N/A)All Cash$126.44 M$4.03$3.80535,7113/31/245.91%52.64%
+CERE12/06/23AbbVie Inc. (ABBV)All Cash$8.7 B$45.00$42.572,766,5096/30/245.71%15.78%
+CALB1/30/24Southern California Bancorp (BCAL)All Stock$100.21 M$23.87$22.6342,8059/30/245.50%8.96%
+NGMS5/14/23Aristocrat Leisure Limited (ALL.AX)All Cash$1.2 B$29.50$27.98513,6855/14/245.41%23.25%
+SMMF8/25/23Burke & Herbert Financial Services Corp. (BHRB)All Stock$371.5 M$28.95$27.4818,3363/31/245.34%47.52%
+CCLP12/19/23Kodiak Gas Services (KGS)All Stock$854 M$2.08$1.97542,0876/30/245.29%14.63%
+OLK10/17/23Thermo Fisher Scientific Inc. (TMO)All Cash$3.1 B$26.00$24.7373,9276/30/245.26%14.55%
+SP10/05/23Metropolis Technologies, Inc. (N/A)All Cash$1.9 B$54.00$51.32185,94512/31/245.22%6.03%
+SQNS8/07/23Renesas Electronics Corporation (N/A)All Cash$249 M$3.03$2.8919,6073/31/244.84%43.13%
+AXNX1/08/24Boston Scientific Corporation (BSX)All Cash$3.17 B$71.00$67.81776,8506/30/244.70%13.01%
+MOR2/05/24Novartis AG (NVS)All Cash$2.90 B$18.28$17.471,371,5516/30/244.64%12.82%
+CSTR10/26/23Old National Bancorp (ONB)All Stock$344.4 M$18.99$18.290,5516/30/244.33%11.98%
+TGAN1/11/24Renesas Electronics Corporation (N/A)All Cash$311.67 M$5.10$4.89327,11512/31/244.29%4.96%
+PXD10/11/23Exxon Mobil Corporation (XOM)All Stock$64.5 B$241.01$231.572,683,5736/30/244.07%11.27%
+KRTX12/22/23Bristol-Myers Squibb (BMY)All Cash$12.7 B$330.00$318.355224,1196/30/243.66%10.11%
+LBAI9/27/22Provident Financial Services, Inc. (PFS)All Stock$1.3 B$12.99$12.585188,4513/31/243.25%28.95%
+NWLI10/09/23Prosperity Life Group (N/A)All Cash$1.9 B$500.00$484.716,7026/30/243.15%8.72%
+FREE2/13/24Sababa Holdings (N/A)All Cash$593.91 M$4.88$4.7400746,5616/30/242.95%8.17%
+HOLI12/11/23Ascendent Capital Partners (N/A)All Cash$1.66 B$26.50$25.75301,7586/30/242.91%8.05%
+DOOR2/09/24Owens Corning (OC)All Cash$3.9 B$133.00$129.721,187,4296/30/242.53%6.99%
+HARP1/08/24Merck & Co., Inc. (MRK)All Cash$371.40 M$23.00$22.435786,3976/30/242.52%6.96%
+EGLE12/11/23Star Bulk Carriers Corp. (SBLK)All Stock$947.77 M$57.74$56.3374,9276/30/242.51%6.94%
+FNCB9/27/23Peoples Financial Services Corp. (PFIS)All Stock$129 M$6.12$5.9816,8066/30/242.35%6.49%
+SWN1/11/24Chesapeake Energy Corporation (CHK)All Stock$7.4 B$6.83$6.6712,786,7586/30/242.34%6.46%
+FGH1/03/24FG Financial Group, Inc. (FGF)All Stock$38.87 M$1.33$1.34683/31/242.31%20.54%
+ZFOX2/06/24Haveli Investments (N/A)All Cash$350 M$1.14$1.115137,7096/30/242.24%6.20%
+HAYN2/05/24North American Stainless (N/A)All Cash$970 M$61.00$59.67142,6529/30/242.23%3.63%
+SOVO8/07/23Campbell Soup Company (CPB)All Cash$2.7 B$23.00$22.531,800,4476/30/242.09%5.77%
+KNTE2/16/24XOMA Corporation (XOMA)Special Conditions-$71.33 M$2.59$2.541,760,0206/30/241.97%5.44%
+TARO1/17/24Sun Pharmaceutical Industries (N/A)All Cash$257.34 M$43.00$42.1844,6216/30/241.94%5.38%
+VIA1/02/24Retailco, LLC (N/A)All Cash$190 M$11.00$10.812,1966/30/241.85%5.12%
+TCN1/19/24Blackstone (BX)All Cash$3.5 B$11.25$11.052,047,2496/30/241.81%5.00%
+KAMN1/19/24Arcline Investment Management (N/A)All Cash$1.8 B$46.00$45.28328,1716/30/241.59%4.40%
+HRT2/16/24General Atlantic and Stone Point Capital (N/A)All Cash$1.65 B$14.35$14.1312,922,9556/30/241.56%4.31%
+PGTI1/17/24MITER Brands (N/A)All Cash$3.1 B$42.00$41.39990,9406/30/241.47%4.08%
+EVBG2/05/24Thoma Bravo (N/A)All Cash$1.5 B$28.60$28.222,925,4446/30/241.35%3.72%
+MDC1/18/24Sekisui House, Ltd. (SKHSY)All Cash$4.83 B$63.00$62.221,207,8456/30/241.25%3.47%
+TAST1/16/24Restaurant Brands International (QSR)All Cash$1 B$9.55$9.435252,7846/30/241.22%3.37%
+LBC11/13/22Washington Federal, Inc. (WAFD)All Stock$654 M$9.65$9.5411,7082/29/241.12%40.78%
+SPLK9/21/23Cisco (CSCO)All Cash$28.45 B$157.00$155.352,539,0699/30/241.06%1.73%
+CBAY2/12/24Gilead Sciences, Inc. (GILD)All Cash$3.26 B$32.50$32.1654,460,7183/31/241.04%9.27%
+VERY10/03/23iA American Holdings, Inc. (N/A)All Cash$170 M$11.43$11.321,7636/30/240.97%2.69%
+DSKE12/22/23TFI International Inc. (TFII)All Cash$1.12 B$8.30$8.225288,9966/30/240.91%2.52%
+CVLY12/12/23Orrstown Financial Services, Inc. (ORRF)All Stock$207 M$23.70$23.4913,1749/30/240.91%1.48%
+AMAM1/08/24Johnson & Johnson (JNJ)All Cash$1.33 B$28.00$27.75943,2076/30/240.90%2.49%
+AYX12/18/23Clearlake Capital and Insight Partners (N/A)All Cash$4.4 B$48.25$47.861,516,2116/30/240.81%2.25%
+SNCE1/29/24eMed, LLC (N/A)All Cash-$33.40 M$5.75$5.7113,1463/31/240.70%6.24%
+CATC9/19/23Eastern Bankshares, Inc. (EBC)All Stock$528 M$68.00$67.5830,4493/31/240.62%5.48%
+TGH10/22/23Stonepeak (N/A)All Cash$7.4 B$50.00$49.75166,9643/31/240.50%4.47%
+CPE1/04/24APA Corporation (APA)All Stock$4.5 B$32.92$32.781,413,4616/30/240.43%1.20%
+ROVR11/29/23Blackstone (N/A)All Cash$2.3 B$11.00$10.971,182,1603/31/240.27%2.43%
+FRLN11/22/23Syncona Ltd (N/A)All Cash-$9.91 M$6.50$6.495,4532/20/240.15%56.24%
+RYZB12/26/23Bristol Myers Squibb (BMY)All Cash$3.6 B$62.50$62.44135,4832/22/240.10%11.69%
+AMNB7/25/23Atlantic Union Bankshares Corporation (AUB)All Stock$416.8 M$45.79$45.8113,7193/31/24-0.04%-0.35%
+DOC10/30/23Healthpeak Properties, Inc. (PEAK)All Stock$4.63 B$11.57$11.584,146,7486/30/24-0.12%-0.34%
+CWBC10/11/23Central Valley Community Bancorp (CVCY)All Stock$99.4 M$14.29$14.3216,6494/01/24-0.20%-1.75%
+GRCL12/26/23AstraZeneca (AZN)Special Conditions$1 B$10.00$10.1352,172,6193/31/24-1.33%-11.86%
+ICVX12/12/23AstraZeneca PLC (AZN)Special Conditions$435.14 M$15.00$15.359,311,3473/31/24-2.28%-20.30%
+SIX11/02/23Cedar Fair, L.P. (FUN)All Stock$4.86 B$24.64$25.51455,1676/30/24-3.39%-9.38%
+RAIN12/13/23Pathos AI, Inc. (N/A)Special Conditions-$35.53 M$1.16$1.2100N/A1/31/24-4.13%79.38%
+MGRC1/29/24WillScot Mobile Mini Holdings (WSC)Special Conditions$3.8 B$123.00$128.58377,4756/30/24-4.34%-12.00%
+INBX1/23/24Sanofi (SNY)Special Conditions$2.2 B$30.00$37.65154,3566/30/24-20.32%-56.18%

Disclaimer: I hold long positions in First Financial Northwest (FFNW), Cerevel Therapeutics (CERE), Capri (CPRI) and Genetron Holdings (GTH). Please do your own due diligence before buying or selling any securities mentioned in this article. We do not warrant the completeness or accuracy of the content or data provided in this article.